Please use this identifier to cite or link to this item: https://hdl.handle.net/10316/104552
Title: Peripheral Dopamine Directly Acts on Insulin-Sensitive Tissues to Regulate Insulin Signaling and Metabolic Function
Authors: Tavares, Gabriela 
Martins, Fátima O. 
Melo, Bernardete F.
Matafome, Paulo N. 
Conde, Silvia V.
Keywords: dopamine; insulin signaling; glucose metabolism; lipid metabolism; D1 dopamine receptor; D2 dopamine receptor
Issue Date: 2021
Publisher: Frontiers Media S.A.
Project: GIFT (Grupo de Investigacao Fundamental e Translacional) from the Portuguese Society of Diabetes 
FCT - PD/BD/127822/2016 
FCT - PD/BD/128336/2017 
FCT - contract CEECIND/04266/2017 
Serial title, monograph or event: Frontiers in Pharmacology
Volume: 12
Abstract: Dopamine is a key regulator of glucose metabolism in the central nervous system. However, dopamine is also present in the periphery and may have direct effects on insulin-sensitive tissues. Dopamine receptor 2 (D2R) agonist bromocriptine is a FDA-approved drug for type 2 diabetes. Herein, we explored the role of peripheral dopamine and its receptors in regulating glucose uptake and metabolism on insulin-sensitive tissues. Peripheral dopamine effect in [3H]2-deoxyglucose uptake in insulin-sensitive tissues was tested in vivo in rats. Direct effects on [3H]2-deoxyglucose uptake, insulin receptor phosphorylation, and regulation of metabolic function were tested ex vivo in the liver, soleus muscle, and white and brown adipose tissues. Bromocriptine and the antagonists domperidone, D2R antagonist, and haloperidol, antagonist of both dopamine receptor 1 (D1R) and D2R, were used to disclose dopamine receptors' involvement. Peripheral dopamine increases glucose uptake in vivo. Ex vivo, only dopamine increased glucose uptake in the soleus, while bromocriptine increased it in the liver; the effects were reverted by haloperidol and domperidone, respectively. In adipose tissue, domperidone reverted dopamine- and bromocriptine-mediated potentiation of insulin-induced glucose uptake, but in turn increased the insulin receptor, Akt, AMPK, HSL, ACC, and ACL, phosphorylation. In the soleus muscle, AMPK-phosphorylation increased with bromocriptine and dopamine whose effects were suppressed by domperidone and haloperidol. In conclusion, peripheral dopamine stimulates glucose uptake with its receptors being differentially involved in glucose uptake in insulin-sensitive tissues. Dopamine also has a role in lipid metabolism in white adipose tissue. Altogether, these results suggest that peripheral modulation of the dopaminergic system should be further evaluated as a putative therapeutic approach for metabolic disorders.
URI: https://hdl.handle.net/10316/104552
ISSN: 1663-9812
DOI: 10.3389/fphar.2021.713418
Rights: openAccess
Appears in Collections:I&D ICBR - Artigos em Revistas Internacionais
I&D CIBB - Artigos em Revistas Internacionais

Files in This Item:
File Description SizeFormat
fphar-12-713418.pdf2.69 MBAdobe PDFView/Open
Show full item record

SCOPUSTM   
Citations

21
checked on Jun 3, 2024

WEB OF SCIENCETM
Citations

20
checked on Jun 2, 2024

Page view(s)

69
checked on Jun 11, 2024

Download(s)

21
checked on Jun 11, 2024

Google ScholarTM

Check

Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons